Blau Farmacêutica S.A. (BVMF:BLAU3)

Market Cap	2.35B
Revenue (ttm)	1.75B
Net Income (ttm)	217.21M
Shares Out	177.68M
EPS (ttm)	1.22
PE Ratio	10.82
Forward PE	8.28
Dividend	0.36 (2.78%)
Ex-Dividend Date	Mar 24, 2025

Volume	120,200
Average Volume	239,051
Open	13.19
Previous Close	13.26
Day's Range	13.09 - 13.49
52-Week Range	9.20 - 17.61
Beta	0.35
RSI	59.77
Earnings Date	Mar 19, 2025

About Blau Farmacêutica

Blau Farmacêutica S.A., a pharmaceutical company provides high-complpexity drugs in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States. Its medications cover various segments, such as immunology, hematology, oncology, nephrology, infectious diseases, anesthesiology, and others. The company provides uterine stimulator; anesthetics; feminine health care; oncological products; antivirals and antiretrovirals; acid pump inhibitor; antithrombotic; antirheumatic; antibiotics; biopharmaceuticals; essential hospital produc...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 1,900
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: BLAU3

Financial Performance

In 2024, Blau Farmacêutica's revenue was 1.75 billion, an increase of 27.81% compared to the previous year's 1.37 billion. Earnings were 217.21 million, a decrease of -13.05%.